Last reviewed · How we verify
systemic clarithromycin
At a glance
| Generic name | systemic clarithromycin |
|---|---|
| Also known as | antibiotic |
| Sponsor | Universidade Estadual Paulista Júlio de Mesquita Filho |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia (PHASE3)
- S. Aureus Decolonization in HPN Patients. (NA)
- A Drug-Drug Interaction Study Between ATI-2173 and Midazolam or Clarithromycin in Healthy Subjects (PHASE1)
- To Evaluate the Effect of Clarithromycin on the Systemic Exposure of Pacritinib in Healthy Subjects (PHASE1)
- Impact of Periodontal Treatment on Gastric Helicobacter Pylori Eradication (PHASE1)
- Corticosteroid Therapy for Chronic Rhinosinusitis Without Nasal Polyps (CRSsNP) (PHASE4)
- Nonsurgical Periodontal Treatment Associated or Not With Systemic Antibiotics and Photodynamic Therapy (NA)
- Periodontal Debridement Associated With Systemic Antibiotics and Single/Repeated PDT to Treat Aggressive Periodontitis (PHASE2, PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: